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SUMMARY 
The synthesis and purification of a component of fireMaster BP-6 and 
fireMaster FF-1, 2,3',4,4',5-pentabromobiphenyl, is described. The compound 
was found to be a potent inducer of liver microsomal drug-metabolizing enzymes 
in the rat, enhancing those enzymic activities induced by both phenobarbitone 
and 3-methylcholanthrene (i.e. cytochromes P-450 and P-448). The pcntabromo- 
biphenyl enhanced the activities of benzo[a]pyrene hydroxylase, dimethylamino- 
antipyrine N-demethylase and NADPH-cytochrome c reductase. The hepatic cyto- 
chromes b and P-450 were increased and the Soret peak maximum of the latter 
was shiftzd to 448.5 nm. The relative peak intensities and spectral shifts 
for the ethylisocyanide-binding difference spectra confirmed the mixed induc- 
tion characteristics of 2,3',4,4',5-pentabromobiphenyl. 
INTRODUCTION 
In 1973 and 1974 large quantities of an industrial flame retardant 
(fireMaster), containing among other chemicals a complex mixture of poly- 
brominated biphenyls (PBBs) were inadvertantly introduced into Michigan's 
food supply. Exposure of farm animals, farm families and the consuming public 
to fireMaster followed (1,2). The need to identify the composition, the 
biologic effects and the persistc>nce of fireMaster became apparent. 
Induction of the hepatic microsomal drug-metabolizing enzymes has been 
widely used to compare the biologic effects of various chemicals. Inducers 
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of these enzymes are often categorized as phenobarbitone(PB)-type inducers of 
cytochrome P-450- or 3-methylcholanthrene(MC)-type inducers of cytochrome P-448. 
dependent monooxygenase activities. In rats and mice fireMaster is a potent 
inducer of hepatic microsomal enzymes, producing a pattern of induction con- 
sistent with the simultaneous induction of cytochromes P-450 and P-448 (3,4). 
For several classes of halogenated aromatic hydrocarbons [chlorinated 
biphenyls (5,6), dibenzo-p-dioxins and dibenzofurans (7), azobenzenes and 
azoxybenzenes (8)] there appears to be a good correlation between the toxicity 
of the chemical and its ability to induce cytochrome P-448. It is of parti- 
cular interest, therefore, to identify those brominated biphenyls present in 
fireMaster which are capable of inducing cytochrome P-44%. 
Only one substance in fir&faster, namely the 2,3',4,4',5,5'-hexabromo- 
biphenyl, has been found capable of inducing cytochrome P-448 (9). 
This study describes the synthesis and purification of a component of 
fireMaster which is a potent inducer of cytochrome P-448. 
METHODS 
(syntheses) 
2,4,5-Tribromoaniline was synthesized from 2,5-dibromoaniline (Aldrich) 
by bromination with liquid bromine in carbon tetrachloride in the presence of 
iron metal filings. Various batches yielded products between 90 and 99.5% 
pure after methanol/water recrystalization. The major impurity in each batch 
was the starting material. The proton nuclear magnetic resonance (NMR) 
spectrum of the product showed 3 singlets at 4.13, 6.98 and 7.57 ppm. 
2,3',4,4',5-Pentabromobiphenyl(PBBp) was synthesized by the diazo 
coupling (10) of 2,4,5-tribromoaniline and g-dibromobenzene (Aldrich). The 
products were purified by alumina/Florisil column chromatography to remove 
possible brominated dibenzofuran impurities followed by repeated thin-layer 
chromatography on silica gel HF254 to separate the two major products, 
PBBp and 2,2',3',4,5-pentabromobiphenyl. PBBp was further purified by methan- 
ol recrystalization. The NMR proton spectrum confirmed the identification 
of PBBp as 2,3',4,4',5-pentabromobiphenyl with singlets at 7.92 and 7.54 
ppm, doublets at 7.63 [J = 2.0 Hz] and 7.68 [J = 8.2 Hz] ppm and a quartet 
centered at 7.17 ppm. The proton chemical shifts for PBBp are consistent 
with published data (11). 
By gas chromatographic (GC) response and by comparison with known 
standards,PBBp was found to be 96.14% pure and was contaminated with the 
following: 2.83% 2,3',4',5-tetrabromobiphenyl (TBBp), 0.82% 2,2',3',5- 
tetrabromobiphenyl with 0.21% unidentified. 
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A sample of the major impurity, TBBp,was kindly supplied by Drs. 
G. Sundstri;m and 0. Hutzinger. The synthetic TBBp was found by GC response 
to be greater than 99% pure and was used without further cleanup. The 
synthesis, purification and identification of TBBp have been described (12). 
(Biochemicals) 
Cytochrome c (horse heart, type III), NADP', NADPH, a-D-glucose-6- 
phosphate, a-D-glucose-&phosphate dehydrogenase (Baker's yeast), MC, benzo- 
[alpyrene (B[a]P) and ethylisocyanide (EIC) were purchased from Sigma Chemical 
co. ; 4-dimethylaminoantipyrine (DMAP) from Aldrich Chemical Co.; carbon 
monoxide (CO) (research purity) from Matheson, and PB from the Ontario Veteri- 
nary College, Guelph. [3H]-B[a]P was obtained from New England Nuclear Co. 
and purified by thin-layer chromatography using hexane as eluant. 
(Animal treatment and isolation of microsomes) 
One month old male Wistar rats, average weight 100 g, were housed in 
wire cages and allowed free access to Purina Certified Rodent Chow #5002 and 
water. PBBp was dissolved in corn oil and doses of 30 Jmol Kg-1 (low dose) 
and 150 pmol ~g-1 (high dose) were administered to four animals at each dose 
level by intraperitoneal injection (ca. 0.5 ml) on days 1 and 3. The animals 
were killed by cervical dislocation on day 6. TBBp was administered in a 
similar manner only at the 150 nmol Kg-l dose level. PB (400 urn01 Kg-l) 
dissolved in isotonic saline and X(100 umol Kg-l) dissolved in corn oil were 
administered (ca. 0.5 ml) individually as well as coadministered to animals on 
days 1 and 2 and the animals killed on day 3. Animals injected with corn oil 
(ca. 0.5 ml) served as controls. All animals were fasted over the last 24 
hours to lower liver glycogen levels. 
(Assays) 
In all assays the final concentration of microsomal protein was 1.0 mg 
ml -1 as determined by the method of Lowry et al.(13). The cytochrome P-450 -- 
content was determined by the method of Omura and Sato (14), from the CO- 
difference spectrum of dithionite-reduced microsomes using an extinction 
coefficient of 91 cm-l m~-l between Amax and A4gO. The EIC-difference spec- 
trum was determined in a similar manner to the CO-difference spectrum except 
that EIC was added to the sample cuvette (final concentration 4.5 mM) instead 
of co. The concentration of cytochrome b5 was determined from the difference 
spectrum between NADH-reduced microsomes and oxidised microsomes (15) using 
the corrected extinction coefficient of 185 cm-l mM-1 (14). All spectra were 
recorded on a Cary 118C spectrophotometer with a repetitive scan accessory. 
Holmium oxide was used to calibrate all spectra. 
The rate of oxidative N-demethylation of DMAP was measured by quanti- 
fying the production of formaldehyde as described (16). The formaldehyde, 
trapped as the semicarbazone, was developed in double strength Nash reagent 
(17). The rate of B[a]P hydroxylation was measured by the radiometric assay 
of DePierre et al. -- (18) as improved by Nesnow et al.(lV), by quantifying the -7 base-soluble metabolites following hexane-extraction of the unreacted B[a]P. 
Because an NADPH-regenerating system was employed in both metabolic assays, 
all tubes were preincubated for 15 minutes. The activity of NADPH-cytochrome 
P-450 reductase was measured by the rate of reduction of cytochrome c (20). 
To prolong the linearity of the cytochrome c reduction, samples with high 
NADPH-cytochrome P-450 reductase activity were diluted to a final microsomal 
protein concentration of 0.2 mg ml-l. 
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RESULTS 
The effects of pretreatment with corn oil, PB, MC, PB plus MC, PBBp 
and TBBp on the hepatic drug-metabolizing enzymes are shown in Table 1. 
The activity of DMAP N-demethylase and of NADPH-cytochrome c reductase 
was increased by pretreatment with PB, PBBp and TBBp but not by MC. PBBp 
induced these enzymic activities more than TBBp. Since TBBp was administered 
at more than 30-times the concentration injected as a contaminant in PBBp, 
the results suggest that PBBp is itself a PB-type inducer of cytochrome 
P-450-dependent enzymic activity. 
Pretreatment with PB and TBBp increased the activity of B[a]P 
hydroxylase by 3.2- and 2.8-fold, respectively. In contrast, the activity 
was stimulated 15.2-fold by MC-pretreatment and 17.1-fold by pretreatment 
with PBBp at the high dose level. At the lower dose level of 30 pmol Kg -1 , 
PBBp-pretreatment enhanced the activity of B[a]P hydroxylase by 14.7-fold 
indicating that PBBp was a potent inducer of cytochrome P-448-dependent 
monooxygenase activity. 
The concentrations of cytochrome b5 and cytochrome P-450 were 
increased by PBBp-pretreatment, The increase in cytochrome P-450 was 
accompanied by a hypsochromic shift in the CO-difference spectrum 
from 450.0 nm to 448.5 nm. Both Soret peaks of the EIC- 
difference spectrum were shifted: from 428.0 to 428.6 nm and 
from 455.0 to 453.0 nm. The ratio of the two Soret peak heights (455: 
428) increased from 0.49 (controls) to 1.1 and 1.5 for the low and high 
dose, respectively. The qualitative spectral characteristics displayed by 
PBBp-induced microsomes were intermediate between PB- and MC-induced micro- 
somes. 
The pattern of enzymic activities and the spectral characteristics of 
PBBp-induced microsomes were simulated by the coadministration of PB and MC. 
This indicates that PBBp-pretreatment resulted in a mixed-type induction of 
both cytochromes P-450 and P-448. 
178 
Vol. 92, No. 1, 1980 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
179 
Vol. 92, No. 1, 1980 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
DISCUSSION 
FireMaster BP-6 and FF-1 are commercial mixtures of brominated bfphenyls 
possessing both PB and MC inducing characteristics. Two components, comprising 
more than 80% of fireMaster, namely the 2,, 7',4,4',5,5'-hexabromobiphenyl and 
2,2',3,4,4',5,5'-heptabromobiphenyl, were PB-type inducers (21, 22). 
Aust and coworkers reported that 2,3' ,4,4',5,5'-hexabromobiphenyl, 
isolated from fireMaster, was a mixed-type inducer and thereby identified the 
first component of fireMaster which causes MC-type effects (9). In this 
report PBBp has also been shown to be a mixed-type inducer. Using the activity 
of B[a]P hydroxylase as an index of cytochrome P-448-dependent monooxygenase 
activity, it can be concluded that PBBp is a potent inducer of MC-type charac- 
teristics with almost maximum effects observed at the relatively low dose of 
30 ymole Kg 
-1 
. Recently the chloro analog of PBBp, the 2,3',4,4',5-pentachlo- 
robiphenyl, was shown in our laboratory to be a mixed-type inducer. The 
properties of PBBp, which together with the other pentabromobiphenyl, 2,2',4,5, 
S'-pentabromobiphenyl, comprises up to 8% of fireMaster mixtures (23), strongly 
suggests that PBBp contributes significantly to the MC-type characteristics 
of the commercial PBB mixtures. 
The identification of PBBp as a mixed-type inducer may be significant 
not only in terms of explaining the inducing properties of fireMaster but 
also in terms of toxicity. It has been suggested for several classes of 
halogenated aromatic hydrocarbons, including polychlorinated biphenyls, that 
a correlation exists between various toxic responses to a chemical and its 
ability to induce cytochrome P-448. It has yet to be shown whether this 
generalization can be extended to include the brominated biphenyls. 
Pharmacokinetic studies in vivo have revealed that the individual PBBs -__ 
in fireMaster are eliminated from the rat at different rates (24). Due to 
this differential rate of elimination, those components more slowly removed 
from the body appear to become more concentrated relative to the other PBB 
isomers and congeners. PBBp is among those components which apparently 
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concentrate in mammals. Metabolic studies in vitro produced similar results -~ 
in that, due to differential rates of metabolism, PBBp, as well as other 
poorly metabolized components of fireMaster, appeared to concentrate within 
the PBB mixture (25). These results show that PBBp is a persistent chemical. 
This correlates with reports which have demonstrated that 2,3',4,4',5- 
pentachlorobiphenyl, a component of commercial PCBs, preferentially biocon- 
centrates in human adipose tissue and breast milk (26). 
In conclusion, PBBp has been identified as mixed-type inducer of both 
cytochromes P-450 and P-448. The present data concerning the toxicity of 
several classes of halogenated aromatic hydrocarbons suggest that PBBp is 
potentially toxic. It is interesting to speculate that the persistence of 
PBBp in mammals together with its potential toxicity may explain in part why 
PBBs derived from contaminated beef and poultry were more toxic to mink than 
the original fireMaster (27). 
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